These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34271184)

  • 21. Markers of mast cell degranulation.
    Hogan AD; Schwartz LB
    Methods; 1997 Sep; 13(1):43-52. PubMed ID: 9281467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Idiopathic Anaphylaxis: A Form of Mast Cell Activation Syndrome.
    Giannetti MP; Akin C; Castells M
    J Allergy Clin Immunol Pract; 2020 Apr; 8(4):1196-1201. PubMed ID: 32276688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathology of extramedullary mastocytosis.
    Doyle LA; Hornick JL
    Immunol Allergy Clin North Am; 2014 May; 34(2):323-39. PubMed ID: 24745677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mast cell-restricted tetramer-forming tryptases and their beneficial roles in hemostasis and blood coagulation.
    Prieto-García A; Castells MC; Hansbro PM; Stevens RL
    Immunol Allergy Clin North Am; 2014 May; 34(2):263-81. PubMed ID: 24745673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doctor, I Think I Am Suffering from MCAS: Differential Diagnosis and Separating Facts from Fiction.
    Valent P; Akin C
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1109-1114. PubMed ID: 30961836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Massive release of the histamine-degrading enzyme diamine oxidase during severe anaphylaxis in mastocytosis patients.
    Boehm T; Reiter B; Ristl R; Petroczi K; Sperr W; Stimpfl T; Valent P; Jilma B
    Allergy; 2019 Mar; 74(3):583-593. PubMed ID: 30418682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mast cell activation syndrome: High frequency of skin manifestations and anaphylactic shock.
    Casassa EA; Mailhol C; Tournier E; Laurent C; Degboe Y; Eischen M; Kirsten N; Moreau J; Evrard SM; Mansat-De Mas V; Lamant L; Dubreuil P; Apoil PA; Hermine O; Paul C; Bulai Livideanu C
    Allergol Int; 2019 Jan; 68(1):119-121. PubMed ID: 30097253
    [No Abstract]   [Full Text] [Related]  

  • 28. Diagnostic criteria and classification of mastocytosis in 2014.
    Akin C; Valent P
    Immunol Allergy Clin North Am; 2014 May; 34(2):207-18. PubMed ID: 24745670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management.
    Castells M; Butterfield J
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1097-1106. PubMed ID: 30961835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current options in the treatment of mast cell mediator-related symptoms in mastocytosis.
    Escribano L; Akin C; Castells M; Schwartz LB
    Inflamm Allergy Drug Targets; 2006 Jan; 5(1):61-77. PubMed ID: 16613565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generalized pruritus relieved by NSAIDs in the setting of mast cell activation syndrome.
    Kesterson K; Nahmias Z; Brestoff JR; Bodet ND; Kau A; Kim BS
    J Allergy Clin Immunol Pract; 2018; 6(6):2130-2131. PubMed ID: 29577987
    [No Abstract]   [Full Text] [Related]  

  • 32. INTERACTIVE MEDICAL CASE. A Stinging Sensation.
    Lee-Sarwar K; Vaidya A; Shi M; Akin C
    N Engl J Med; 2015 Jun; 372(26):e35. PubMed ID: 26107069
    [No Abstract]   [Full Text] [Related]  

  • 33. Nonclonal Mast Cell Activation Syndrome: A Growing Body of Evidence.
    Hamilton MJ
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):469-481. PubMed ID: 30007464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.
    Schwartz LB; Metcalfe DD; Miller JS; Earl H; Sullivan T
    N Engl J Med; 1987 Jun; 316(26):1622-6. PubMed ID: 3295549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insect Sting Anaphylaxis-Or Mastocytosis-Or Something Else?
    Golden DBK; Carter MC
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1117-1123. PubMed ID: 30961837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mast cell and mast cell disease.
    Longley J; Duffy TP; Kohn S
    J Am Acad Dermatol; 1995 Apr; 32(4):545-61; quiz 562-4. PubMed ID: 7896943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal Involvement in Mast Cell Activation Disorders.
    Hsieh FH
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):429-441. PubMed ID: 30007461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population.
    Rottem M; Okada T; Goff JP; Metcalfe DD
    Blood; 1994 Oct; 84(8):2489-96. PubMed ID: 7522630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenic and diagnostic relevance of KIT in primary mast cell activation disorders.
    Muñoz-González JI; García-Montero AC; Orfao A; Álvarez-Twose I
    Ann Allergy Asthma Immunol; 2021 Oct; 127(4):427-434. PubMed ID: 34298172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anaphylactic reaction to white-faced hornet sting and elevated baseline (asymptomatic) serum tryptase.
    Lieberman P; Schwartz LB
    J Allergy Clin Immunol Pract; 2013; 1(3):315. PubMed ID: 24565497
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.